Top

Reactions Weekly

Published in:

01-07-2023 | Hydroxychloroquine | Case report

Multiple drugs

DRESS syndrome and off label use: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

The occurrence of DRESS syndrome after fondaparinux-sodium initiation was captured as reported in the source document.

Minenna E, et al. Sustained drug-related reaction with eosinophilia and systemic symptoms (DRESS) triggered by low molecular weight heparins in COVID-19: management and precision diagnosis. Postepy Dermatologii i Alergologii 39: 816-818, No. 4, Jan 2022

Title: Multiple drugs
DRESS syndrome and off label use: case report
Publication date: 01-07-2023
Publisher: Springer International Publishing
Keywords: Hydroxychloroquine
SARS-CoV-2
Fondaparinux
Enoxaparin
Cetirizine
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-42844-9

2024 ASCO Annual Meeting

Springer Medicine

Multiple drugs

DRESS syndrome and off label use: case report

Excerpt

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Elasomeran

Bupropion/charcoal

Insulin lispro

Isotretinoin

Azd-1222

Multiple drugs